Quarterly report pursuant to Section 13 or 15(d)

DEFERRED RD OBLIGATIONS PARTICIPATION AGREEMENTS (Details Narrative)

v3.24.2.u1
DEFERRED RD OBLIGATIONS PARTICIPATION AGREEMENTS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
DEFERRED RD OBLIGATIONS PARTICIPATION AGREEMENTS        
Research and development expense $ 0 $ 309,400 $ 0 $ 434,430
Contra R&D expense related to personnel and third-party expenses $ 0 $ 77,391 $ 0 $ 108,665